Sugi Predict

Sugi Predict / Compounds / SCHEMBL2983533

SCHEMBL2983533

SCHEMBL2983533

Cc1cc(N)cc2cc[nH]c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.38
▸ REN P00797 1/20 0.37
▸ BRPF1 P55201 2/20 0.36
▸ BRD4 O60885 1/20 0.36
▸ TAF1 P21675 1/20 0.36
▸ CREBBP Q92793 1/20 0.36
▸ CECR2 Q9BXF3 1/20 0.36
▸ BRD9 Q9H8M2 1/20 0.36
▸ PDE10A Q9Y233 1/20 0.34
▸ CYP2A6 P11509 1/20 0.34
▸ KEAP1 Q14145 1/20 0.34
▸ IKBKB O14920 3/20 0.33
▸ CHUK O15111 3/20 0.33
▸ GRM5 P41594 2/20 0.33
▸ TSHR P16473 1/20 0.33
▸ RPS6KA3 P51812 1/20 0.33
▸ AHR P35869 1/20 0.32
▸ CASP1 P29466 1/20 0.32
▸ CFB P00751 1/20 0.32
▸ PDPK1 O15530 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4798726 0.78 CYP1A2 (0.40) RENBRPF1BRD4TAF1CREBBP
SCHEMBL16815127 0.78 IKBKB (0.35) BRPF1BRD4TAF1CREBBPCECR2
SCHEMBL4484912 0.77 AHR (0.47) RENBRPF1BRD4TAF1CREBBP
SCHEMBL14363462 0.77 GPR84 (0.34) IKBKBCHUKAHRPDPK1
SCHEMBL3584001 0.75 AHR (0.45) RENBRPF1BRD4TAF1CREBBP
SCHEMBL1997793 0.75 ALOX15 (0.45) BRPF1BRD4TAF1CREBBPCECR2
SCHEMBL2599709 0.75 AHR (0.45) RENBRPF1BRD4TAF1CREBBP
SCHEMBL18639225 0.75 REN (0.37) ALDH1A1RENBRPF1BRD4TAF1
SCHEMBL3961345 0.75 TNF (0.42) IKBKBCHUKAHRPDPK1
SCHEMBL8346876 0.75 REN (0.37) ALDH1A1RENBRPF1BRD4TAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118852180-A Alkylated benzo 3, 6-dihydropyrrole [3,2-E ] indole molecule and preparation method, application, hydrogen storage method and hydrogen release method thereof 北京化工大学 2024-10-29 — — CN disclosed
US-9522150-B2 Alpha adrenergic receptor modulators ALLERGAN, INC. (US) 2016-12-20 — — US disclosed
EP-2029543-B1 SUBSTITUTED 3-CYANOPYRIDINES AS PROTEIN KINASE INHIBITORS WYETH LLC (US) 2015-11-18 — — EP disclosed
US-20150209351-A1 Alpha Adrenergic Receptor Modulators ALLERGAN, INC. 2015-07-30 — — US disclosed
US-7781591-B2 Substituted 3-cyanopyridines as protein kinase inhibitors WYETH LLC (US) 2010-08-24 — — US disclosed
EP-2029543-A2 SUBSTITUTED 3-CYANOPYRIDINES AS PROTEIN KINASE INHIBITORS Wyeth (US) 2009-03-04 — — EP disclosed
WO-2007146376-A2 SUBSTITUTED 3-CYANOPYRIDINES AS PROTEIN KINASE INHIBITORS WYETH (US) 2007-12-21 — — WO disclosed
US-20070287708-A1 Substituted 3-cyanopyridines as protein kinase inhibitors WYETH LLC 2007-12-13 — — US disclosed
US-6723741-B2 ANALGESICS, SEDATIVES, ANESTHETICS SYNAPTIC PHARMACEUTICAL CORPORATION 2004-04-20 — — US disclosed
US-20030105147-A1 Benzimidazoles and benzothiazoles and uses thereof SYNAPTIC PHARMACEUTICAL CORPORATION 2003-06-05 — — US disclosed
US-6498177-B2 ALPHA 2 ADRENERGIC RECEPTOR AGONIST; ANALGESIC, SEDATIVE AND ANAESTHETIC AGENTS SYNAPTIC PHARMACEUTICAL CORPORATION 2002-12-24 — — US disclosed
US-20020049239-A1 Novel indole and benzothiazole derivatives SYNAPTIC PHARMACEUTICAL CORPORATION 2002-04-25 — — US disclosed
US-6303643-B1 THERAPY OF MIGRAINE HEADACHE, HYPERTENSION, ALCOHOL WITHDRAWAL, DRUG ADDICTION, RHEUMATOID ARTHRITIS, PRESBYOPIA, ISCHEMIC PAIN, SPASTICITY, DIARRHEA, NASAL CONGESTION, AND URINARY INCONTINENCE BY ADMINISTERING BENZOTHIAZOLE DERIVATIVE SYNAPTIC PHARMACEUTICAL CORPORATION 2001-10-16 — — US disclosed
EP-0900080-A4 NOVEL INDOLE AND BENZOTHIAZOLE DERIVATIVES SYNAPTIC PHARMA CORP (US) 2000-12-13 — — EP disclosed
US-6159998-A Substituted indoles and uses thereof SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-12-12 — — US disclosed
US-6040451-A USED AS ANALGESIC, SEDATIVE AND ANAESTHETIC AGENTS SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-03-21 — — US disclosed
US-5948804-A ANAESTHETIC PREMEDICATION SYNAPTIC PHARMACEUTICAL CORPORATION (US) 1999-09-07 — — US disclosed
EP-0900080-A1 NOVEL INDOLE AND BENZOTHIAZOLE DERIVATIVES SYNAPTIC PHARMACEUTICAL CORPORATION (US) 1999-03-10 — — EP disclosed
US-5677321-A ANESTHETIC PREMEDICATION SYNAPTIC PHARMACEUTICAL CORPORATION (US) 1997-10-14 — — US disclosed
WO-1997031636-A1 NOVEL INDOLE AND BENZOTHIAZOLE DERIVATIVES SYNAPTIC PHARMACEUTICAL CORPORATION (US) 1997-09-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150209351-A1 Alpha Adrenergic Receptor Modulators ADRB1, ADRB2, ADRA2C ALDH1A1 497/4885REN 174/4885BRPF1 673/4885
US-20020049239-A1 Novel indole and benzothiazole derivatives ADRB2, ADRB1, CNR2 ALDH1A1 456/4885REN 253/4885BRPF1 3219/4885
US-20030105147-A1 Benzimidazoles and benzothiazoles and uses thereof ADRB2, BDKRB2, ADRB1 ALDH1A1 323/4885REN 219/4885BRPF1 1906/4885
US-20070287708-A1 Substituted 3-cyanopyridines as protein kinase inhibitors CNKSR1, MAP3K1, MAP3K7 ALDH1A1 2828/4885REN 470/4885BRPF1 1749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.